Clinical Focus Targeted rapid diagnostics for transplant and autoimmune care plus COVID-19 create sales opportunities with hospitals, transplant centers, and specialty clinics seeking fast triage and monitoring tools. The RALI-Dx IL-6 Severity Triage Test and related assays offer both point-of-care and laboratory options to support clinical decision-making. Leverage cross-sell potential with the direct-to-consumer COVID-19 Home Antibody Test to engage patient-facing programs and telehealth platforms.

Manufacturing Scale Strong manufacturing scale-up funding and public-sector backing position SQI as a potential contract manufacturing partner for other diagnostics startups and health systems. FedDev Ontario support enables ramping production, accelerating commercialization, and entering regional procurement channels. Target hospital networks, medtech distributors, and system integrators seeking scalable rapid diagnostic manufacturing partnerships.

Channel Expansion Existing direct-to-consumer and point-of-care tests indicate channel diversification beyond traditional laboratories. Engage telehealth providers, specialty clinics, and consumer health retailers to accelerate adoption of home antibody testing and RALI-fast solutions, with opportunities for bundled offerings and payer-friendly test panels. Consider cross-selling across the RALI portfolio to boost per-customer revenue.

Lung Cancer Opportunity FirstLook Lung signals expansion into cancer screening; pursue partnerships with radiology groups, lung cancer screening programs, and employer health initiatives to deploy blood-based screening tests. Look for collaborations with clinical labs for integrated screening workflows and explore alignment with TORdx LUNG development for multi-modality lung assessment paths.

Regulatory Momentum Regulatory momentum such as Health Canada interim order authorization demonstrates the ability to navigate approvals and accelerate customer onboarding. Leverage regulatory credibility to engage national health systems, insurers, and international partners seeking compliant rapid diagnostics. Position SQI to shorten sales cycles through reference sites and payer discussions.